Seaport Therapeutics
2 known investors
Seaport Therapeutics develops therapeutics and medicines. The company is led by a founder with extensive experience building biotech platforms and advancing novel drug development programs.
BiotechMental Health
Founders & leadership
DZ
Daphne ZoharFounder, CEO and Board Member
Investors · 2
In the news
- Seaport Therapeutics Q1 2026 results and cash runway | SPTX Quarterly Report (10-Q)stocktitan.net · 2026
- Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress - AOLaol.com · 2026
- Intellectiaintellectia.ai · 2026
- Seaport Therapeutics raises about $255 million in upsized IPO | Reutersreuters.com · 2026
- Two biotechs raise a combined $556M in latest spurt of IPOs | BioPharma Divebiopharmadive.com · 2026
- Seaport Therapeutics, a neuroscience biotech, adds $225 million to its coffersstatnews.com · 2024